Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a Locations section listing Connecticut as a study site and removed the older Connecticut Locations entry and the HHS Vulnerability Disclosure in the prior revision.
    Difference
    0.2%
    Check dated 2025-12-24T14:43:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    25 days ago
    No Change Detected
  6. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:54:08.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    A note clarifying that publications are automatically filled from PubMed was added, and the page revision tag was updated to v3.3.1. The previous PubMed-related note and the older revision tag (v3.2.0) were removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:03.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Summary
    The government funding and operating status banner at the top of the page has been removed. The rest of the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:00:05.000Z thumbnail image
  9. Check
    61 days ago
    Change Detected
    Summary
    No significant changes to core study content are visible between the two screenshots; the page still shows the same study details and structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:21:12.000Z thumbnail image
  10. Check
    89 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:17:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.